Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Fehse

Showing results (41-50 of 207) with videos related to

Pageof 21
Sort By:
Experimental Hematology|December 23, 2008
Quantitative monitoring of NPM1 mutations provides a valid minimal residual disease parameter following allogeneic stem cell transplantationUlrike Bacher, Anita Badbaran, Boris Fehse, et al.
Gene Therapy|April 19, 2021
Automated production of CCR5-negative CD4<sup>+</sup>-T cells in a GMP-compatible, clinical scale for treatment of HIV-positive patientsLea Isabell Schwarze, Tanja Sonntag, Stefan Wild, et al.
Leukemia & Lymphoma|May 3, 2008
Overexpression of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase inhibits GM-CSF-dependent colony formation of CD34+ hematopoietic progenitor cellsElion Hoxha, Boris Fehse, Gerhard Ortmeyer, et al.
International Journal of Molecular Sciences|September 13, 2016
Digital PCR Panel for Sensitive Hematopoietic Chimerism Quantification after Allogeneic Stem Cell TransplantationTanja Stahl, Caroline Rothe, Manja U Böhme, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 24, 2011
Cancer suicide gene therapy with TK.007: superior killing efficiency and bystander effectEllen Preuss, Alexander Muik, Kristoffer Weber, et al.
Scientific Reports|September 19, 2014
Novel lentiviral vectors with mutated reverse transcriptase for mRNA delivery of TALE nucleasesUlrike Mock, Kristoffer Riecken, Belinda Berdien, et al.
Oncotarget|August 27, 2016
Potent in vitro and in vivo effects of polyclonal anti-human-myeloma globulinsAneta Schieferdecker, Ofer Shoshani, Benedikt Westner, et al.
Bone Marrow Transplantation|January 20, 2022
Digital-droplet PCR assays for IDH, DNMT3A and driver mutations to monitor after allogeneic stem cell transplantation minimal residual disease of myelofibrosisDaniele Mannina, Anita Badbaran, Christine Wolschke, et al.
Molecular Therapy. Methods & Clinical Development|September 6, 2021
LATE-a novel sensitive cell-based assay for the study of CRISPR/Cas9-related long-term adverse treatment effectsDawid Głów, Simon Meyer, Irene García Roldán, et al.
Human Vaccines & Immunotherapeutics|February 23, 2013
Influenza virus-specific TCR-transduced T cells as a model for adoptive immunotherapyBelinda Berdien, Henrike Reinhard, Sabrina Meyer, et al.
Pageof 21

Showing results (41-50 of 207) with videos related to

Sort By:
Pageof 21
Experimental Hematology|December 23, 2008
Quantitative monitoring of NPM1 mutations provides a valid minimal residual disease parameter following allogeneic stem cell transplantationUlrike Bacher, Anita Badbaran, Boris Fehse, et al.
Gene Therapy|April 19, 2021
Automated production of CCR5-negative CD4<sup>+</sup>-T cells in a GMP-compatible, clinical scale for treatment of HIV-positive patientsLea Isabell Schwarze, Tanja Sonntag, Stefan Wild, et al.
Leukemia & Lymphoma|May 3, 2008
Overexpression of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase inhibits GM-CSF-dependent colony formation of CD34+ hematopoietic progenitor cellsElion Hoxha, Boris Fehse, Gerhard Ortmeyer, et al.
International Journal of Molecular Sciences|September 13, 2016
Digital PCR Panel for Sensitive Hematopoietic Chimerism Quantification after Allogeneic Stem Cell TransplantationTanja Stahl, Caroline Rothe, Manja U Böhme, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 24, 2011
Cancer suicide gene therapy with TK.007: superior killing efficiency and bystander effectEllen Preuss, Alexander Muik, Kristoffer Weber, et al.
Scientific Reports|September 19, 2014
Novel lentiviral vectors with mutated reverse transcriptase for mRNA delivery of TALE nucleasesUlrike Mock, Kristoffer Riecken, Belinda Berdien, et al.
Oncotarget|August 27, 2016
Potent in vitro and in vivo effects of polyclonal anti-human-myeloma globulinsAneta Schieferdecker, Ofer Shoshani, Benedikt Westner, et al.
Bone Marrow Transplantation|January 20, 2022
Digital-droplet PCR assays for IDH, DNMT3A and driver mutations to monitor after allogeneic stem cell transplantation minimal residual disease of myelofibrosisDaniele Mannina, Anita Badbaran, Christine Wolschke, et al.
Molecular Therapy. Methods & Clinical Development|September 6, 2021
LATE-a novel sensitive cell-based assay for the study of CRISPR/Cas9-related long-term adverse treatment effectsDawid Głów, Simon Meyer, Irene García Roldán, et al.
Human Vaccines & Immunotherapeutics|February 23, 2013
Influenza virus-specific TCR-transduced T cells as a model for adoptive immunotherapyBelinda Berdien, Henrike Reinhard, Sabrina Meyer, et al.
Pageof 21